Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report
Type 2 Diabetes Mellitus (T2DM) is a well-known comorbidity to COVID-19 and coagulopathies are a common accompaniment to both T2DM and COVID-19. In addition, patients with COVID-19 are known to develop micro-c...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Etheresia Pretorius, Chantelle Venter, Gert Jacobus Laubscher, Petrus Johannes Lourens, Janami Steenkamp and Douglas B. Kell Tags: Original investigation Source Type: research
More News: Cardiology | Cardiovascular | COVID-19 | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart